-
Left Ventricular Hypertrophy in Women With a History of Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-11-14 Maria G Hauge,Peter Damm,Klaus F Kofoed,Emma Louise Ries Møller,Andrea G Lopez,Anne S Ersbøll,Marianne Johansen,Per E Sigvardsen,Michael H C Pham,Jens P Goetze,Andreas Fuchs,Jørgen T Kühl,Børge G Nordestgaard,Lars V Køber,Finn Gustafsson,Jesper J Linde
BACKGROUND As a hypertensive disorder of pregnancy, preeclampsia is associated with increased cardiovascular morbidity and mortality later in life. Since early signs of myocardial affection could indicate a higher risk of future cardiovascular disease manifestations, we investigated whether women with prior preeclampsia have a higher prevalence of left ventricular hypertrophy compared with women from
-
Irisin Improves Preeclampsia by Promoting Embryo Implantation and Vascular Remodeling. Hypertension (IF 6.9) Pub Date : 2024-11-14 Dawei Zhu,Jie Huang,Yujie Wu,Lin Fan,Yijun Liu,Qianwen Zhang,Li Li,Jian Han,Xinghui Liu
BACKGROUND Preeclampsia is a pregnancy-specific disorder with unclear pathogenesis. Irisin, a recently identified exercise-induced factor, significantly influences lipid metabolism and cardiovascular function. Nonetheless, its role in trophoblast development during human placentation and the related intracellular signaling pathways remain poorly understood. METHODS We assessed peripheral blood irisin
-
Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation. Hypertension (IF 6.9) Pub Date : 2024-11-14 Giuseppe Mancia,Rita Facchetti,Fosca Quarti-Trevano,Guido Grassi
BACKGROUND In the absence of outcome-based ambulatory blood pressure (BP) data hypertension guidelines provide 24-hour mean BP values corresponding to trial-validated office BP values. Data are shown for untreated and treated patients together, but whether corresponding ambulatory values are similar in untreated and treated hypertensives and reproducible at yearly measurements during treatment is undefined
-
Exposure to Volatile Organic Compounds and Blood Pressure in NHANES 2011 to 2018. Hypertension (IF 6.9) Pub Date : 2024-11-13 Katlyn E McGraw,Arce Domingo-Relloso,Daniel W Riggs,Danielle N Medgyesi,Raghavee Neupane,Jeanette A Stingone,Tiffany R Sanchez
BACKGROUND Volatile organic compounds (VOCs) are ubiquitous environmental pollutants. Exposure to VOCs is associated with cardiovascular disease risk factors, including elevated blood pressure in susceptible populations. However, research in the general population, particularly among nonsmoking adults, is limited. We hypothesized that higher VOC exposure is associated with higher blood pressure and
-
Mechanistic Insights Into Redox Damage of the Podocyte in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-11-13 Daria V Ilatovskaya,Amanda Behr,Alexander Staruschenko,Gentzon Hall,Oleg Palygin
Podocytes are specialized cells within the glomerular filtration barrier, which are crucial for maintaining glomerular structural integrity and convective ultrafiltration. Podocytes exhibit a unique arborized morphology with foot processes interfacing by slit diaphragms, ladder-like, multimolecular sieves, which provide size and charge selectivity for ultrafiltration and transmembrane signaling. Podocyte
-
Genetics of Hypertension: Additive and Interactive Effects. Hypertension (IF 6.9) Pub Date : 2024-11-11 Zdenka Pausova,Johanne Tremblay,Pavel Hamet
-
Blood Pressure Regulation in Post-COVID POTS: Beyond Sinus Tachycardia. Hypertension (IF 6.9) Pub Date : 2024-11-11 Madeleine Johansson,Marcus Ståhlberg,Fabrizio Ricci,Christian Lewinter,Viktor Hamrefors,Peter M Nilsson,Richard Sutton,Artur Fedorowski
BACKGROUND Postural orthostatic tachycardia syndrome (POTS) is a frequently diagnosed cardiovascular disorder after COVID-19 infection. POTS is characterized by the presence of excessive sinus tachycardia on standing without a fall in blood pressure (BP). We investigated the BP profile using 24-hour ambulatory BP monitoring in patients with new-onset POTS after COVID-19 compared with prepandemic population-based
-
Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats. Hypertension (IF 6.9) Pub Date : 2024-11-06 Soumiya Pal,Ashim K Bagchi,David S Henry,Reid D Landes,Shengyu Mu,Sung W Rhee,Nancy J Rusch,Amanda J Stolarz
BACKGROUND Hypertension increases the risk of lymphedema in patients with comorbidities, but whether hypertension directly compromises lymph vessel (LV) function and lymph flow is unclear. We compared the contractions of mesenteric LVs ex vivo and lymph flow in vivo between normotensive and Ang II (angiotensin II)-induced hypertensive rats and explored the ionic basis of contractile patterns. Key studies
-
Evolutionary Characteristics in Primary Aldosteronism Patients. Hypertension (IF 6.9) Pub Date : 2024-11-06 Yinjie Gao,Yu Wang,Yue Zhou,Xiaoyan Chang,Yushi Zhang,Min Nie,Anli Tong
BACKGROUND Primary aldosteronism is predominantly caused by excessive aldosterone production from the adrenal cortex, and the aldosterone-producing structures could take many forms, like adenomas, nodules, micronodules, and so on. Most studies of primary aldosteronism were limited to the hotspot driver genes responsible for autonomous aldosterone production; however, the panoramic genetic architecture
-
Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults. Hypertension (IF 6.9) Pub Date : 2024-10-28 Zhijia Sun,Haijun Zhang,Yinqi Ding,Canqing Yu,Dianjianyi Sun,Yuanjie Pang,Pei Ling Yang,Yiping Chen,Huaidong Du,Weijie Hu,Daniel Avery,Junshi Chen,Zhengming Chen,Liming Li,Jun Lv,
BACKGROUND Recent guidelines recommend antihypertensive drug treatment for prehypertensive individuals with blood pressure between 130/80 and 139/89 mm Hg. This study evaluates the cost-effectiveness of 3 interventions in Chinese prehypertensive adults: salt substitution, antihypertensive drug treatment, and their combination. METHODS We developed a Markov cohort model to estimate cardiovascular disease
-
Self-Guided Blood Pressure Screening in the Community, Opportunities, and Challenges. Hypertension (IF 6.9) Pub Date : 2024-10-25 Edel T O'Hagan,Simone L Marschner,Shiva Mishra,Haeri Min,Aletta E Schutte,Markus P Schlaich,Patrick Hannebery,Noel Duncan,Tim Shaw,Clara K Chow
BACKGROUND Community-based health check kiosks provide opportunities to improve the detection and long-term monitoring of hypertension. We describe the sociodemographic and cardiovascular characteristics of first-time and repeat users of these kiosks. METHOD This was an observational study. Deidentified data collected from 430 SiSU Health consumer-facing health check stations in pharmacies across Australia
-
20-HETE, Blood Pressure, and Vascular Stiffness in Young Adults. Hypertension (IF 6.9) Pub Date : 2024-10-23 Anne Barden,Sujata Shinde,Lawrence J Beilin,Michael Phillips,Brendan Adler,Trevor A Mori
BACKGROUND Cytochrome-P450 eicosanoids from arachidonic acid, including vasodilator epoxyeicosatrienoic acids (EETs) and the vasoconstrictor 20-HETE, are important in regulating blood pressure, vascular tone, and cardiac and renal function. This study examined plasma 20-HETE and EETs in relation to blood pressure and vascular stiffness in a cohort of 1054 community-dwelling young adults from the Raine
-
Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-10-23 Olivia Nonn,Olivia Debnath,Daniela S Valdes,Katja Sallinger,Ali Kerim Secener,Cornelius Fischer,Sebastian Tiesmeyer,Jose Nimo,Thomas Kuenzer,Juliane Ulrich,Theresa Maxian,Martin Knöfler,Philipp Karau,Hendrik Bartolomaeus,Thomas Kroneis,Alina Frolova,Lena Neuper,Nadine Haase,Alexander Malt,Niklas Müller-Bötticher,Kristin Kräker,Sarah Kedziora,Désirée Forstner,Roland Eils,Ruth Schmidt-Ullrich,Sandra
BACKGROUND Preeclampsia is a severe hypertensive disorder in pregnancy that causes preterm delivery, maternal and fetal morbidity, mortality, and life-long sequelae. Understanding the pathogenesis of preeclampsia is a critical first step toward protecting mother and child from this syndrome and increased risk of cardiovascular disease later in life. However, effective early predictive tests and therapies
-
Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension. Hypertension (IF 6.9) Pub Date : 2024-10-21 Kazuomi Kario,David E Kandzari,Felix Mahfoud,Michael A Weber,Roland E Schmieder,Konstantinos Tsioufis,Minglei Liu,Michael Böhm,Raymond R Townsend
-
8-Aminopurines: A Promising New Direction for Purine-Based Therapeutics. Hypertension (IF 6.9) Pub Date : 2024-10-21 Edwin K Jackson,Stevan P Tofovic,Yuanyuan Chen,Lori A Birder
-
Somatic GNAQ, CTNNB1, and CACNA1C Mutations in Cat Aldosterone-Secreting Tumors. Hypertension (IF 6.9) Pub Date : 2024-10-21 Alice Watson,Harriet Syme,Morris Brown
BACKGROUND Primary aldosteronism (PA) is a common cause of human hypertension. Somatic mutations in KCNJ5, CACNA1D, ATP1A1, and ATP2B3 are found in at least 80% of aldosterone-producing adenomas, which cause unilateral PA in humans. Somatic mutations have been identified infrequently in 7 other genes; few of these were known to play a role in aldosterone secretion before the discovery of their mutations
-
Ultraprocessed Food Consumption and Hypertension Risk in the REGARDS Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-10-17 Carol R Oladele,Neha Khandpur,Spencer Johnson,Vivien Wambugu,Ya Yuan,Timothy B Plante,Gina S Lovasi,Suzanne Judd
BACKGROUND This study examined the longitudinal association between ultraprocessed food (UPF) consumption and overall hypertension risk and explored the contribution of UPF to racial disparities in risk for hypertension. METHODS We analyzed data from 5957 participants from the REGARDS cohort study (Reasons for Geographic and Racial Disparities in Stroke) free from hypertension during visit 1 (2003-2007)
-
Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-10-17 Bálint Vékony,Gábor Nyirő,Zoltan Herold,János Fekete,Filippo Ceccato,Sven Gruber,Lydia Kürzinger,Mirko Parasiliti-Caprino,Fabio Bioletto,Nikolette Szücs,Attila Doros,Bálint Kende Szeredás,Siti Khadijah Syed Mohammed Nazri,Vanessa Fell,Mohamed Bassiony,Magdolna Dank,Elena Aisha Azizan,Irina Bancos,Felix Beuschlein,Peter Igaz
BACKGROUND Distinguishing between unilateral and bilateral primary aldosteronism, a major cause of secondary hypertension, is crucial due to different treatment approaches. While adrenal venous sampling is the gold standard, its invasiveness, limited availability, and often difficult interpretation pose challenges. This study explores the utility of circulating microRNAs (miRNAs) and machine learning
-
Tackling POTS Needs More Than Just a Sympathetic Approach. Hypertension (IF 6.9) Pub Date : 2024-10-16 Melanie Dani,Artur Fedorowski
-
Young Athlete With Hypertension and Hypokalemia. Hypertension (IF 6.9) Pub Date : 2024-10-16 Antoine-Guy Lopez,Dominique Guerrot
We describe a 17-year-old woman diagnosed with severe hypertension during routine follow-up after the prescription of a combined oral contraceptive pill. Initially, due to her age, the estradiol-containing contraception, and high-level sport practice, physicians suspected drug-induced hypertension. Blood tests showed hypokalemia, and further investigations revealed pseudoaldosteronism. After the exclusion
-
Pediatric High Blood Pressure Recognition Associated With Electronic Decision Support: A Cohort Analysis. Hypertension (IF 6.9) Pub Date : 2024-10-16 Justin P Zachariah,Tavleen Singh,Shannon Collinson,Justin Rahman,Alisa Acosta,Jessica F Campbell,Mary Hoang,Katharine E Sigler,Elizabeth Onugha,Shweta Shah,S Kristen Sexson-Tejtel,Mark Farrior,Scott Watson
BACKGROUND Pediatric high blood pressure (BP) predicts future cardiovascular disease events. High BP is improperly measured, underrecognized, and undermanaged especially in disadvantaged populations. In a large, diverse, academic pediatric practice, we detail the associations of a comprehensive initiative with high BP provider recognition. METHODS A comprehensive BP initiative was promulgated including
-
Transient High Salt Intake Promotes T-Cell-Mediated Hypertensive Vascular Injury. Hypertension (IF 6.9) Pub Date : 2024-10-16 Mina Yakoub,Masudur Rahman,Patricia Kleimann,Jasmina Hoffe,Milena Feige,Pascal Bouvain,Christina Alter,Jennifer-Isabel Kluczny,Sophia Reidel,Rianne Nederlof,Lydia Hering,Doron Argov,Denada Arifaj,Marta Kantauskaite,Jaroslawna Meister,Markus Kleinewietfeld,Lars Christian Rump,Jonathan Jantsch,Ulrich Flögel,Dominik N Müller,Sebastian Temme,Johannes Stegbauer
BACKGROUND Dietary high salt (HS) intake has a strong impact on cardiovascular diseases. Here, we investigated the link between HS-aggravated immune responses and the development of hypertensive vascular disease. METHODS ApolipoproteinE-deficient mice were transiently treated with HS (1% NaCl) via drinking water for 2 weeks, followed by a washout period, and subsequent Ang II (angiotensin II) infusion
-
Evidence for Baroreceptor Activity During Carotid Artery Applanation. Hypertension (IF 6.9) Pub Date : 2024-10-16 Joshua M Cherubini,Genie J Y Lau,Elric Y Allison,Maureen J MacDonald
-
Postpartum Blood Pressure Variability and Heart Rate Variability in Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-10-15 Anne-Sophie van Wingerden,Maria Katsidoniotaki,Noora Haghighi,Casandra Almonte,Helen Woolcock Martinez,Eduard Valdes,Pedro Castro,Aymen Alian,Whitney Booker,Natalie Bello,Randolph S Marshall,Ioannis A Kougioumtzoglou,Nils Petersen,Eliza Miller
BACKGROUND Preeclampsia is associated with autonomic dysregulation during pregnancy; however, less is known about autonomic function in the first week postpartum after preeclampsia. METHODS We retrospectively analyzed data from a prospective cohort of women with and without preeclampsia. Continuous blood pressure and heart rate were measured with finger plethysmography within 7 days postpartum. Frequency-domain
-
Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis. Hypertension (IF 6.9) Pub Date : 2024-10-15 Zhouyangfan Peng,Xue-Yang Luo,Xinyi Li,Yapei Li,Yusi Wu,Yuyang Tian,Bingjie Pan,Aleksandar Petrovic,Djuro Kosanovic,Ralph Theo Schermuly,Clemens Ruppert,Andreas Günther,Zhen Zhang,Chengfeng Qiu,Ying Li,Jun Pu,Xiaohui Li,Alex F Chen
BACKGROUND Pulmonary hypertension (PH) is a fatal progressive disease characterized by pulmonary endothelial injury and occlusive pulmonary vascular remodeling. Lysosomal protease cathepsin L degrades essential molecules to participate in the human pathophysiological process. BMPR2 (bone morphogenetic protein type II receptor) deficiency, an important cause of PH, results from mutational inactivation
-
Aortic-Femoral Stiffness Gradient and Cardiovascular Risk in Older Adults. Hypertension (IF 6.9) Pub Date : 2024-10-07 Keeron Stone,Simon Fryer,Barry J McDonnell,Michelle L Meyer,James Faulkner,Mohsen Agharazii,Catherine Fortier,Christopher J A Pugh,Craig Paterson,Gabriel Zieff,Aiden Chauntry,Anna Kucharska-Newton,Martin Bahls,Lee Stoner
BACKGROUND The aortic-femoral arterial stiffness gradient, calculated as the ratio of lower-limb pulse-wave velocity (PWV) to central (aortic) PWV, is a promising tool for assessing cardiovascular disease (CVD) risk, but whether it predicts incident CVD is unknown. METHODS We examined the association of the aortic-femoral arterial stiffness gradient measures carotid-femoral stiffness gradient (femoral-ankle
-
Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-10-02 Francesca Torresan,Federico B Rossi,Ilaria Caputo,Sofia Zanin,Brasilina Caroccia,Andrea Mattarei,Michela Paccagnella,Eva Kohlscheen,Teresa M Seccia,Maurizio Iacobone,Gian-Paolo Rossi
BACKGROUND Primary aldosteronism (PA), the most common curable salt-dependent form of arterial hypertension, features renal K+ loss and enhanced Na+ reabsorption. We investigated whether the electrolyte, water, and TonEBP (tonicity-responsive enhancer binding protein)/NFAT5 (nuclear factor of activated T cells 5) content is altered in the skin of patients with PA and corrected by surgical cure. METHODS
-
Personal Genetic-Hypertension Odyssey From Phenotypes to Genotypes and Targets. Hypertension (IF 6.9) Pub Date : 2024-10-02 Friedrich C Luft
Hypertension requires increased systemic vascular resistance. Thus far, Mendelian hypertension-related genes are related to salt retention, an indirect regulatory effect. With the identification of mutated, overactive, PDE3A (phosphodiesterase 3A), we have uncovered a more direct vasoconstrictive mechanism. The autosomal-dominant syndrome features another specific phenotype, brachydactyly type E. Hypertension
-
Awakening to the Pertinence of Sleep for Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-30 Tomoyuki Tobushi,John S Floras
-
Maternal Hypertension and Fecundability: A Population-Based Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-27 Wenxue Xiong,Lu Han,Xijia Tang,Rui Li,Wen Chen,Xiaohua Liu,Hua Nie,Weibing Qin,Li Ling
BACKGROUND The association of hypertension and blood pressure control with fecundability among women is not yet elucidated. The purpose of this study was to evaluate the hypothesis that maternal preconception hypertension would be associated with reduced fecundability and that blood pressure control could reduce excess risk. METHODS Using the National Free Preconception Checkup Projects in Guangdong
-
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in PA. Hypertension (IF 6.9) Pub Date : 2024-09-25 Yuto Hayama,Emiko Kuribayashi-Okuma,Norihiko Fujii,Fumika Ochiai-Homma,Osamu Yamazaki,Yuya Tsurutani,Tetsuo Nishikawa,Shigeru Shibata
BACKGROUND Aldosterone and the MR (mineralocorticoid receptor) are important therapeutic targets for hypertension and cardiovascular diseases. However, biomarkers of tissue MR signaling are not fully established. Extracellular vesicles released from eukaryotic cells can provide information on tissue signaling. Using samples from patients with primary aldosteronism (PA), we explored the potential of
-
Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control: The 2022 COH Mid-Career Award for Research Excellence. Hypertension (IF 6.9) Pub Date : 2024-09-24 Samuel B R Lawton,Valerie A Wagner,Pablo Nakagawa,Jeffrey L Segar,Curt D Sigmund,Lisa L Morselli,Justin L Grobe
The American Heart Association has identified obesity as a primary impediment to ongoing improvements in cardiovascular diseases, including hypertension. Although drugs, exercise, diets, and surgeries can each cause weight loss, few subjects maintain a reduced weight over the long term. Dysfunctional integrative control (ie, adaptation) of resting metabolic rate (RMR) appears to underlie this failed
-
Intact NOX2 in T Cells Mediates Pregnancy-Induced Renal Damage in Dahl SS Rats. Hypertension (IF 6.9) Pub Date : 2024-09-20 John Henry Dasinger,Justine M Abais-Battad,Samuel D Walton,Emily C Burns-Ray,Mary Cherian-Shaw,Kaitlyn E Baldwin,Daniel J Fehrenbach,David L Mattson
BACKGROUND Hypertensive disorders of pregnancy are associated with increased risk for cardiovascular disease, renal disease, and mortality. While the exact mechanisms remain unclear, T cells and reactive oxygen species have been implicated in its pathogenesis. We utilized Dahl salt-sensitive (SS), SSCD247-/- (Dahl SS CD247 knockout rat; lacking T cells), and SSp67phox-/- (Dahl SS p67phox [NOX2 (NADPH
-
Prevalence and Risk Factors for Secondary Hypertension in Young Adults. Hypertension (IF 6.9) Pub Date : 2024-09-19 Jean-Baptiste de Freminville,Margherita Gardini,Antoine Cremer,Scarlett Camelli,Stephanie Baron,Guillaume Bobrie,Philippe Gosse,Romain Boulestreau,Nicole Gebara,Julien Doublet,Thomas Dussartre,Christine Grataloup,Aurélien Lorthioir,Christine Massien,Anne-Marie Madjalian,Julien Riancho,Gilles Soulat,Nicolas Postel-Vinay,Michel Azizi,Bastien Rance,Laurence Amar
BACKGROUND The prevalence of secondary causes of hypertension in young adults is unknown, and therefore, there is no consensus about the indication of screening of secondary hypertension (2HTN) in this population. The objective was to report the prevalence and the causes of 2HTN in young subjects. METHODS In this cross-sectional study, 2090 patients with confirmed hypertension aged 18 to 40 years with
-
Clinical Trial Evidence of the Gut Microbial Metabolite Butyrate in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-18 Leticia Camargo Tavares,Francine Z Marques
-
Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum. Hypertension (IF 6.9) Pub Date : 2024-09-18 Sean W Dooley,Usman A Tahir,Jennifer L Cluett
-
Association of High Blood Pressure With Post-Traumatic Stress Disorder in Ukrainian Women Refugees. Hypertension (IF 6.9) Pub Date : 2024-09-18 Anna Shalimova,Maria Simona Stoenoiu,Narcis-George Manolache,Wiesław J Cubała,Michel Burnier,Krzysztof Narkiewicz,Alexandre Persu
-
Systolic Blood Pressure, Cardiovascular Health, and Neurocognitive in Adolescents. Hypertension (IF 6.9) Pub Date : 2024-09-18 Stephen R Hooper,Marc B Lande,Joseph T Flynn,Coral D Hanevold,Kevin E Meyers,Joshua Samuels,Richard C Becker,Stephen R Daniels,Bonita E Falkner,Michael A Ferguson,Julie R Ingelfinger,Lisa J Martin,Mark Mitsnefes,Phillip Khoury,Jangdong Seo,Elaine M Urbina
BACKGROUND We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White
-
Dysregulated Mitochondrial Calcium Causes Spiral Artery Remodeling Failure in Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-09-18 Xiyuan Lu,Yifan Wang,Na Geng,Zhiguo Zou,Xueqing Feng,Yuehong Wang,Zhice Xu,Ning Zhang,Jun Pu
BACKGROUND Calcium deficiency in women is strongly linked to an increased risk of developing preeclampsia. Mitochondrial calcium ([Ca2+]m) homeostasis is essential to regulate vascular smooth muscle cell (VSMC) function. However, the role of [Ca2+]m in preeclampsia development remains largely unknown. METHODS To investigate this, human spiral arteries obtained from normotensive and preeclamptic women
-
Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis. Hypertension (IF 6.9) Pub Date : 2024-09-12 Paul K Whelton,Samantha O'Connell,Katherine T Mills,Jiang He
BACKGROUND Systolic blood pressure (SBP) lowering reduces major cardiovascular disease (CVD) and all-cause mortality. However, the optimal target for SBP lowering remains controversial. METHODS We included trials with random allocation to an SBP <130 mm Hg treatment target and CVD as the primary outcome. Data were extracted from each study independently and in duplicate using a standardized protocol
-
Hypertension-Associated Expenditures Among Privately Insured US Adults in 2021. Hypertension (IF 6.9) Pub Date : 2024-09-10 Ashutosh Kumar,Siran He,Lisa M Pollack,Jun Soo Lee,Omoye Imoisili,Yu Wang,Lyudmyla Kompaniyets,Feijun Luo,Sandra L Jackson
BACKGROUND There are no recent estimates for hypertension-associated medical expenditures. This study aims to estimate hypertension-associated incremental medical expenditures among privately insured US adults. METHODS We conducted a retrospective cohort study using IQVIA's Ambulatory Electronic Medical Records-US data set linked with PharMetrics Plus claims data. Among privately insured adults aged
-
Resistant Hypertension and Mortality: An Observational Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-09 Alejandro de la Sierra,Luis M Ruilope,Natalie Staplin,Manuel Gorostidi,Ernest Vinyoles,Julián Segura,Pedro Armario,Anna Oliveras,Bryan Williams
BACKGROUND Resistant hypertension is characterized by elevated blood pressure (BP) despite using 3 antihypertensive agents. Ambulatory BP monitoring (ABPM) detects the presence of white-coat resistant hypertension (24-hour BP <130/80 mm Hg). The aim of the study was to evaluate risks of death in resistant hypertension compared with controlled hypertension, as well as in ABPM-confirmed (24-hour BP ≥130
-
Genetic Variance in Heparan Sulfation Is Associated With Salt Sensitivity. Hypertension (IF 6.9) Pub Date : 2024-09-09 Jetta J Oppelaar,Bart Ferwerda,Mohamed A Romman,Ghazalah N Sahebdin,Aeilko H Zwinderman,Henrike Galenkamp,S Matthijs Boekholdt,Bert-Jan H van den Born,Rik H G Olde Engberink,Liffert Vogt
BACKGROUND High heritability of salt sensitivity suggests an essential role for genetics in the relationship between sodium intake and blood pressure (BP). The role of glycosaminoglycan genes, which are crucial for salinity tolerance, remains to be elucidated. METHODS Interactions between 54 126 variants in 130 glycosaminoglycan genes and daily sodium excretion on BP were explored in 20 420 EPIC-Norfolk
-
Global Blood Pressure Screening During and After Pregnancy: May Measurement Month 2019. Hypertension (IF 6.9) Pub Date : 2024-09-09 Liza Bowen,Richard J Stevens,Aletta E Schutte,Thomas Beaney,Neil R Poulter,Richard J McManus,Lucy C Chappell
BACKGROUND Hypertensive disorders of pregnancy are associated with high maternal and fetal morbidity and mortality. There are limited global data on the characteristics of women during and after pregnancy hypertension. METHODS May Measurement Month is a global campaign to raise awareness of the importance of blood pressure. Adults (≥18 years) recruited through opportunistic sampling during May 2019
-
Blood Pressure-Lowering Medications, Sodium Reduction, and Blood Pressure. Hypertension (IF 6.9) Pub Date : 2024-09-05 Jing Song,Liangkai Chen,Hui Xiong,Yuan Ma,Sonia Pombo-Rodrigues,Graham A MacGregor,Feng J He
BACKGROUND Both blood pressure-lowering medication and sodium reduction are effective in hypertension control, but whether the effect of sodium reduction differ across blood pressure-lowering medications is unclear. This study aims to evaluate the dose-response effect of sodium intake reduction on blood pressure in treated hypertensive individuals and the impact of different classes of blood pressure-lowering
-
Arm Size Coverage of Popular Over-the-Counter Blood Pressure Devices and Implications in US Adults. Hypertension (IF 6.9) Pub Date : 2024-09-05 Eileen Kaur,Asma Rayani,Tammy M Brady,Kunihiro Matsushita
-
Autonomic Dysregulation in Pulmonary Hypertension: Role of Physical Exercise. Hypertension (IF 6.9) Pub Date : 2024-09-05 Leôncio Lopes Soares,Alexandre Martins Oliveira Portes,Sebastião Felipe Ferreira Costa,Luciano Bernardes Leite,Antônio José Natali
Pulmonary hypertension (PH) is a rare and severe condition characterized by increased pressure in the pulmonary circulation, often resulting in right ventricular failure and death. The autonomic nervous system (ANS) plays a crucial role in the cardiovascular and pulmonary controls. Dysfunction of ANS has been implicated in the pathogenesis of cardiopulmonary diseases. Conversely, dysfunctions in ANS
-
Prevalence of Hyperkalemia and Familial Hyperkalemic Hypertension in 5100 Patients Referred to a Tertiary Hypertension Unit. Hypertension (IF 6.9) Pub Date : 2024-09-04 Martina Tetti,Jacopo Burrello,Marguerite Hureaux,Clarisse Billon,Eric Clauser,Franco Veglio,Franco Rabbia,Barbara Pasini,Annalisa Crisetti,Xavier Jeunemaitre,Paolo Mulatero,Silvia Monticone
BACKGROUND Hyperkalemia is a frequent electrolyte alteration whose prevalence varies widely, depending on the adopted cutoff, the setting (inpatients versus outpatients), and the characteristics of the study population. Familial hyperkalemic hypertension (FHH) is a rare cause of hypertension, hyperkalemia, and hyperchloremic metabolic acidosis. METHODS In this retrospective observational study, we
-
Achieving Equity in Hypertension: A Review of Current Efforts by the American Heart Association. Hypertension (IF 6.9) Pub Date : 2024-09-04 Shakia T Hardy,Valy Fontil,Glenn H Dillon,Daichi Shimbo
The purpose of this article is to summarize disparities in blood pressure (BP) by race in the United States, discuss evidence-based strategies to increase equity in BP, review recent American Heart Association BP equity initiatives, and highlight missed opportunities for achieving equity in hypertension. Over 122 million American adults have hypertension, with the highest prevalence among Black Americans
-
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021. Hypertension (IF 6.9) Pub Date : 2024-09-04 Joshua A Jacobs,Anthony Rodgers,Brandon K Bellows,Inmaculada Hernandez,Nelson Wang,Catherine G Derington,Jordan B King,Alexander R Zheutlin,Paul K Whelton,Brent M Egan,William C Cushman,Adam P Bress
BACKGROUND Antihypertensive medication use patterns have likely been influenced by changing costs and accessibility over the past 3 decades. This study examines the relationships between patent exclusivity loss, medication costs, and national health policies on antihypertensive medication use. METHODS Using 1996 to 2021 Medical Expenditure Panel Survey data of US adults with hypertension taking at
-
Sex Differences in Hypertension and Its Management Throughout Life. Hypertension (IF 6.9) Pub Date : 2024-09-04 Wan-Jin Yeo,Rahul Abraham,Aditya L Surapaneni,Pascal Schlosser,Shoshana H Ballew,Bige Ozkan,Carina M Flaherty,Bing Yu,Joseph V Bonventre,Chirag R Parikh,Paul L Kimmel,Ramachandran S Vasan,Josef Coresh,Morgan E Grams
BACKGROUND The prevalence of hypertension and uncontrolled hypertension may differ by age and sex. METHODS We included participants in the Atherosclerosis Risk in Communities study at seven study visits over 33 years (visit 1: 15 636 participants; mean age, 54 years; 55% women), estimating sex differences in prevalence of hypertension (systolic blood pressure ≥130 mm Hg; diastolic blood pressure ≥80
-
Association of Snoring and Daytime Sleepiness With Subsequent Incident Hypertension: A Population-Based Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-04 Pauline Balagny,Emmanuelle Vidal-Petiot,Sofiane Kab,Justine Frija,Philippe Gabriel Steg,Marcel Goldberg,Marie Zins,Marie-Pia d'Ortho,Emmanuel Wiernik
BACKGROUND There is a strong association between obstructive sleep apnea and hypertension, but the effects of obstructive sleep apnea symptoms on the risk of incident hypertension are not well documented. The aim of this prospective study was to examine whether snoring and sleepiness are associated with incident hypertension. METHODS Data from the French population-based CONSTANCES cohort were analyzed
-
GPER Stimulation Attenuates Cardiac Dysfunction in a Rat Model of Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-09-03 Allan Kardec Nogueira de Alencar,Kenneth F Swan,Smruti Mahapatra,Sarah H Lindsey,Gabriella C Pridjian,Carolyn L Bayer
BACKGROUND Preeclampsia poses a substantial clinical challenge, characterized by maternal hypertension, cardiac dysfunction, and persistent cardiovascular risks for both the mother and offspring. Despite the known roles of the estrogen receptor (GPER [G protein-coupled estrogen receptor]) in placental development, its impact on cardiovascular aspects within a preeclampsia animal model remains unexplored
-
Hypertension and Left Ventricular Strain in Pediatric Chronic Kidney Disease. Hypertension (IF 6.9) Pub Date : 2024-08-28 Alexander J Kula,Yunwen Xu,Garick D Hill,Susan L Furth,Bradley A Warady,Derek K Ng,Jeese Seegmiller,Mark Mitsnefes,
BACKGROUND Left ventricular global longitudinal strain (LV GLS) on echocardiography is a sensitive yet clinically significant marker of myocardial dysfunction. Reduced LV GLS is prevalent in adults with chronic kidney disease and hypertension and is associated with adverse cardiovascular outcomes. It may be a biomarker of chronic kidney disease-associated myocardial dysfunction in children, but data
-
Collecting Duct Pro(Renin) Receptor Contributes to Unilateral Ureteral Obstruction-Induced Kidney Injury via Activation of the Intrarenal RAS. Hypertension (IF 6.9) Pub Date : 2024-08-22 Renfei Luo,Kevin T Yang,Fei Wang,Huaqing Zheng,Tianxin Yang
BACKGROUND Although the concept of the intrarenal renin-angiotensin system (RAS) in renal disease is well-described in the literature, the precise pathogenic role and mechanism of this local system have not been directly assessed in the absence of confounding influence from the systemic RAS. The present study used novel mouse models of collecting duct (CD)-specific deletion of (pro)renin receptor (PRR)
-
Hypertensive Disorders of Pregnancy and Brain Health in Midlife: The CARDIA Study. Hypertension (IF 6.9) Pub Date : 2024-08-20 Xiaqing Jiang,Pamela J Schreiner,Erica P Gunderson,Kristine Yaffe
BACKGROUND To understand the role of hypertensive disorders of pregnancy (HDP), including preeclampsia and gestational hypertension (GH), in brain health earlier in life, we investigated the association of HDP with midlife cognition and brain health. METHODS We studied a prospective cohort of women, baseline age 18 to 30 years, who were assessed at study years 25 and 30 with a cognitive battery and
-
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension. Hypertension (IF 6.9) Pub Date : 2024-08-20 Danchen Wu,Ross D Jansen-van Vuuren,Asish Dasgupta,Ruaa Al-Qazazi,Kuang-Hueih Chen,Ashley Y Martin,Jeffrey D Mewburn,Elahe Alizadeh,Patricia D A Lima,Oliver Jones,Pierce Colpman,Rachel E T Bentley,M Martin VandenBroek,Nolan M Breault,Isaac M Emon,V Siddartha Yerramilli,Luka Jedlovčnik,Yuan Yuan Zhao,Michael Wells,Gopinath Sutendra,Mark L Ormiston,Stephen L Archer
BACKGROUND Drp1 (dynamin-related protein 1), a large GTPase, mediates the increased mitochondrial fission, which contributes to hyperproliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension (PAH). We developed a potent Drp1 GTPase inhibitor, Drpitor1a, but its specificity, pharmacokinetics, and efficacy in PAH are unknown. METHODS Drpitor1a's ability to inhibit recombinant
-
Predictive and Diagnostic Value of the Angiogenic Proteins in Patients With Chronic Kidney Disease. Hypertension (IF 6.9) Pub Date : 2024-08-20 Nir Melamed,John C Kingdom,Lei Fu,Paul M Yip,Isabel Arruda-Caycho,Dini Hui,Michelle A Hladunewich
BACKGROUND Our objective was to investigate the predictive and diagnostic accuracy of the angiogenic proteins sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) for preterm preeclampsia and explore the relationship between renal function and these proteins. METHODS We completed a blinded, prospective, longitudinal, observational study of patients with chronic kidney disease
-
George L. Bakris, MD (1952 to 2024). Hypertension (IF 6.9) Pub Date : 2024-08-14 Rajiv Agarwal,Matthew R Weir
-
Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-08-13 Lisa A Gottlieb,Felix Mahfoud,Stavros Stavrakis,Thomas Jespersen,Dominik Linz
More than 1.5 billion people worldwide have arterial hypertension. Hypertension increases the risks of death and cardiovascular disease, such as atrial fibrillation and heart failure. The autonomic nervous system plays an essential role in hypertension development and disease progression. While lifestyle factors, such as obesity and obstructive sleep apnea, predispose to hypertension by increasing